Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.

Practical Dyspnea Assessment: Relationship Between the 0–10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity

The Treatment of Chronic Cancer Pain in a Cancer Hospital in the Netherlands Rianne de Wit, MS, Frits van Dam, PhD, Ans Vielvoye-Kerkmeer, PhD, Carlien.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Chronic Pain Management in Older Adults: Special Considerations

Is Oxycodone Efficacy Reflected in Serum Concentrations

Factors Correlated with Dyspnea in Advanced Lung Cancer Patients

Clinical Trial Results with OROS® Hydromorphone

Wen Jing Chung, MD, MS, Gregory H. Pharo, DO

Steady-State Kinetics and Dynamics of Morphine in Cancer Patients

An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain Giovambattista.

Chronic Pain Management in Older Adults: Special Considerations

A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations Mary E. Lynch,

Edmonton, Canada: A Regional Model of Palliative Care Development

A Canadian Survey of Cancer Patients’ Experiences

Pain, Fatigue, and Sleep Disturbances in Oncology Outpatients Receiving Radiation Therapy for Bone Metastasis Christine Miaskowski, RN, PhD, FAAN, Kathryn.

Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep Mugdha Gore,

Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine Rainer Sabatowski, MD, Stefan.

The adequacy of the minimum data set assessment of pain in cognitively impaired nursing home residents Jiska Cohen-Mansfield, PhD, ABPP Journal of Pain.

Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients Laura L Adams, PhD, Robert.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Acupressure Bands Are Effective in Reducing Radiation Therapy-Related Nausea Joseph A. Roscoe, PhD, Peter Bushunow, MD, Pascal Jean-Pierre, PhD, Charles.

Exploring the Meaning of Chronic Rejection After Lung Transplantation and Its Impact on Clinical Management and Caregiving Mi-Kyung Song, PhD, RN, Annette.

Delirium in Terminal Cancer

Isaac M. Bromberg, MD Journal of Pain and Symptom Management

Cielito C. Reyes-Gibby, DrPH, Wenyaw Chan, PhD, James L

Transdermal Fentanyl for Chronic Pain in AIDS

Temporary Sympathectomy in the Treatment of Chronic Refractory Angina

Redefining Appropriate Treatment Expectations

Clinical Response to an Outpatient Palliative Care Consultation in Patients With Advanced Cancer and Cancer Pain Sriram Yennurajalingam, MD, Jung Hun.

What do ratings on unidimensional pain and emotion scales really mean

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study Kim Fisher, PhD, Carla Stiles,

Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

Ecological Momentary Assessment of Fatigue in Patients Receiving Intensive Cancer Therapy Eileen Danaher Hacker, PhD, APN, AOCN, Carol Estwing Ferrans,

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients With Sickle Cell Disease Qutaiba A. Tawfic,

Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD

Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time? Sangchoon Jeon, MS, Charles.

Strategies in Pain Management

Cancer Pain Assessment and Management Recommendations by Hospice Nurses Paul A Sloan, MD, Barbara L Vanderveer, BSN, Janet S Snapp, BSN, Mitzi Johnson,

Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer.

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

The Assessment of Cancer Pain in North India

Cancer Pain Education Journal of Pain and Symptom Management

Effect of nebulized furosemide in terminally ill cancer patients with dyspnea Hiroyuki Kohara, MD, PhD, Hiroshi Ueoka, MD, PhD, Keisuke Aoe, MD, PhD,

The impact of demographic and disease-specific variables on pain in cancer patients Tone Rustøen, RN, PhD, Sophie D Fosså, MD, Dr Med Sci, Jon Skarstein,

Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS) G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,

Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH

Margot E. Kurtz, PhD, Jay C. Kurtz, PhD, Charles W

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.

A Scale for Measuring Patient Perceptions of the Quality of End-of-Life Care and Satisfaction with Treatment Daniel P. Sulmasy, OFM, MD, PhD, Jessica.

Psychometric update of the Functional Interference Estimate: a brief measure of pain functional interference Robert J. Ferguson, PhD, Janette Seville,

Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy Gregoris Iconomou, PhD, Angelos Koutras, MD,

Clinical and Economic Impact of Palliative Care Consultation

A Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio Miguel Angel Benítez-Rosario, MD, PhD, Antonio.

A comparison of postprocedural wound care treatments: Do antibiotic-based ointments improve outcomes? Zoe D. Draelos, MD, FAAD, Ronald L. Rizer, PhD,

A Titrated Morphine Analgesic Regimen Comparing Substance Users and Non-Users with AIDS-Related Pain Ronald Kaplan, MD, Joseph Slywka, PhD, Susan Slagle,

Physical Function in Patients with Cancer

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine.

Gerd Inger Ringdal, PhD, Marit S Jordhøy, MD, Stein Kaasa, PhD

Botucatu, Brazil: A Regional Community Palliative Care Model

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell,

Impact of Dyspnea, Pain, and Fatigue on Daily Life Activities in Ambulatory Patients with Advanced Lung Cancer Keiko Tanaka, MD, Tatsuo Akechi, MD, PhD,

Nausea and Vomiting Remain a Significant Clinical Problem

Presentation transcript:

The Use of Controlled-Release Oxycodone for the Treatment of Chronic Cancer Pain Winston C.-V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K. Croghan, MD, Melvin R. Moore, MD, Ali Khojasteh, MD, Robert F. Reder, MD, Robert F. Kaiko, PhD, Barbara J. Buckley Journal of Pain and Symptom Management Volume 16, Issue 4, Pages 205-211 (October 1998) DOI: 10.1016/S0885-3924(98)00064-5

Fig. 1 Mean (± two SE) daily pain intensity scores over the 5-day study period in cancer pain patients treated with CR oxycodone (•) and IR oxycodone (○). Categorical scale of 0 = none, 1 = slight, 2 = moderate, and 3 = severe Journal of Pain and Symptom Management 1998 16, 205-211DOI: (10.1016/S0885-3924(98)00064-5)

Fig. 2 Mean (± two SE) acceptability of therapy scores over the 5-day study period in cancer pain patients treated with CR oxycodone (•) and IR oxycodone (○). Categorical scale of 1 = very poor, 2 = poor, 3 = fair, 4 = good, and 5 = excellent Journal of Pain and Symptom Management 1998 16, 205-211DOI: (10.1016/S0885-3924(98)00064-5)